Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

Videos | Cardiovascular Business

Nick West, M.D., chief medical officer for Abbott, explains the details from a survey of 1,400 patients, physicians and ...

Home September 14, 2020
Home
News | Coronavirus (COVID-19)

September 11, 2020 — The National Institutes of Health (NIH) has launched two of three adaptive clinical trials ...

Home September 11, 2020
Home
News | Heart Valve Technology

September 11, 2020 – Medtronic announced U.S. Food and Drug Administration (FDA) approval of an early feasibility study ...

Home September 11, 2020
Home
Videos | Radial Access

Atlantic Health System’s Morristown Medical Center has opened one of the region’s first radial lounges in its Gagnon ...

Home September 11, 2020
Home
News

September 5, 2020 – The TIDES-ACS Randomized Controlled Trial results were published end of July 2020 confirming the ...

Home September 10, 2020
Home
Videos | Drug-Eluting Balloons

Juan F. Granada, M.D., CEO of the Cardiovascular Research Foundation (CRF) worked on preclinical development work for a ...

Home September 09, 2020
Home
News | Vena Cava Filters

September 9, 2020 — The Society of Interventional Radiology (SIR) published new clinical practice guidelines that ...

Home September 09, 2020
Home
News | EP Lab

September 8, 2020 — Researchers developed a new class of medical instruments equipped with an advanced soft electronics ...

Home September 08, 2020
Home
News | Peripheral Artery Disease (PAD)

September 4, 2020 — The U.S. Centers for Medicare and Medicaid Services (CMS) granted a New Technology Add-on Payment ...

Home September 04, 2020
Home
Abbott Espirit BTK Bioresorbable stent, or bioresorbable vascular scaffold (BVS) measures 99 microns and is made from poly-L-lactide (PLLA), a semi-crystalline bioresorbable polymer engineered to resist vessel recoil and provide a platform for drug delivery. Abbott Absorb
Feature | Stents Bioresorbable

September 3, 2020 — Abbott today announced the start of the LIFE-BTK clinical trial to evaluate the safety and ...

Home September 03, 2020
Home
News | Antiplatelet and Anticoagulation Therapies

September 2, 2020 — An international, first-of-its-kind cardiology trial used personalized genetic testing to reduce by ...

Home September 02, 2020
Home
Videos | TCT

With COVID-19 forcing all medical conferences to go virtual in 2020, Juan F. Granada, M.D., CEO of the Cardiovascular ...

Home August 01, 2020
Home
News | Radial Access

August 25, 2020 – Atlantic Health System’s Morristown Medical Center has opened one of the region’s first radial lounges ...

Home August 25, 2020
Home
Navin Kapur, M.D., FAHA, FACC, FSCAI, executive director, The CardioVascular Center for Research and Innovation (CVCRI), explains the concpet of the Door-to-Unloading (DTU) Trial he is heading, one of several innovations at Tufts Medical Center in Boston. Kapur is also director, Acute Mechanical Circulatory Support Program; director, interventional research laboratories; director of Cardiac Biology Research Center, Molecular Cardiology Research Institute (MCRI), Tufts Medical Center. Photo by Dave Fornell
Feature | Tufts Medical Center | Dave Fornell, Editor

The cardiology program at Tufts Medical Center in Boston is internationally recognized for being on the forefront of ...

Home August 21, 2020
Home
News | Left Atrial Appendage (LAA) Occluders

August 21, 2020 — According to a report published by Research Dive, the rising number of patients suffering from atrial ...

Home August 21, 2020
Home
Subscribe Now